moomoo ID:NaN
Log Out
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > CNTB Connect Biopharma > Company Executives
CNTB Connect Biopharma
Post Mkt Price
NamePositionSalaryService DateEducationAgeGenderUpdated
Dr. Zheng Wei, PhDChief Executive Officer and Director------58male03/31/2022
Mr. Steven ChanChief Financial Officer------50male03/31/2022
Dr. Selwyn Ho, M.B.B.S.Chief Business Officer------51male03/31/2022
Dr. Chin LeeChief Medical Officer------52male03/31/2022
Dr. Wubin Pan, PhDChairman of the Board and President------57male03/31/2022
Ms. Jean I. LiuDirector------53female03/31/2022
Dr. Kleanthis G. Xanthopoulos,PhDLead Independent Director------63male03/31/2022
Ms. Karen J. WilsonIndependent Director------58female03/31/2022
Dr. Derek DiRocco, PhDIndependent Director------41male03/31/2022
Dr. Kan Chen, PhDIndependent Director------40male03/31/2022
Company Overview More
Connect Biopharma Holdings Ltd. engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. Its lead product candidate, CBP-201, is an antibody designed to target interleukin-4 receptor alpha, or IL-4Ra, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma. The company was founded by Zheng Wei and Wu Bin Pan on November 23, 2015 and is headquartered in Taicang, China.
CEO: Dr. Zheng Wei, PhD
Market: NASDAQ
Listing Date: 03/19/2021
Hot List
SymbolLatest price%Chg